FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890427865> ?p ?o ?g. }

• W2890427865 abstract "Non-small cell lung cancer (NSCLC) is a leading cause of death worldwide. MicroRNAs (miRNAs) have been indicated as crucial actors in cancer biology. Accumulating evidence suggests that miRNAs can be used as diagnostic and prognostic markers for NSCLC. The purpose of this study was to characterize and identify the novel biomarker miR-4317 and its targets in NSCLC. The expression of miR-4317 was analyzed by in situ hybridization (ISH) and quantitative reverse transcription polymerase chain reaction (qRT-PCR). The effect of miR-4317 on proliferation was evaluated through 3–4,5-dimethylthiazol-2-yl-5-3–carboxymethoxyphenyl-2-4-sulfophenyl-2H-tetrazolium (MTS) and colony formation assays, and cell migration and invasion were evaluated through transwell assays. The expression of target proteins and downstream molecules was analyzed by qRT-PCR and western blot. Dual-luciferase reporter assay was used to assess the target genes of miR4317 in NSCLC cells. Our results demonstrated that miR-4317 was downregulated in NSCLC tissues and serum, particularly in lymph node metastasis and advanced clinical stage tissues. Kaplan-Meier survival analysis showed that NSCLC patients with high expression of miR-4317 exhibited better overall survival (OS). Enhanced expression of miR-4317 significantly inhibited proliferation, colony formation, migration and invasion, and hampered cycles of NSCLC cell lines in vitro. Our results suggested that miR-4317 functions by directly targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). In concordance with in vitro studies, mouse xenograft, lung, and brain metastatic studies validated that miR-4317 functions as a potent suppressor miRNA of NSCLC in vivo. Systemically delivered agomiR-4317 reduced tumor growth and inhibited FGF9 and CCND2 protein expression. Reintroduction of FGF9 and CCND2 attenuated miR-4317-mediated suppression of migration and invasion in NSCLC. Our results indicate that miR-4317 can reduce NSCLC cell growth and metastasis by targeting FGF9 and CCND2. These findings provide new evidence of miR-4317 as a potential non-invasive biomarker and therapeutic target for NSCLC." @default.
• W2890427865 created "2018-09-27" @default.
• W2890427865 creator A5006543483 @default.
• W2890427865 creator A5024958140 @default.
• W2890427865 creator A5044630419 @default.
• W2890427865 creator A5046597133 @default.
• W2890427865 creator A5049384131 @default.
• W2890427865 creator A5058338777 @default.
• W2890427865 creator A5061203415 @default.
• W2890427865 creator A5061370921 @default.
• W2890427865 creator A5069139703 @default.
• W2890427865 creator A5073501391 @default.
• W2890427865 creator A5074866697 @default.
• W2890427865 date "2018-09-18" @default.
• W2890427865 modified "2023-10-15" @default.
• W2890427865 title "miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)" @default.
• W2890427865 cites W144423133 @default.
• W2890427865 cites W1757407923 @default.
• W2890427865 cites W1767867362 @default.
• W2890427865 cites W1820723315 @default.
• W2890427865 cites W1964401009 @default.
• W2890427865 cites W1974254202 @default.
• W2890427865 cites W1974681197 @default.
• W2890427865 cites W1976285590 @default.
• W2890427865 cites W1981133938 @default.
• W2890427865 cites W1989827688 @default.
• W2890427865 cites W1994548165 @default.
• W2890427865 cites W2006797972 @default.
• W2890427865 cites W2010040408 @default.
• W2890427865 cites W2018234708 @default.
• W2890427865 cites W2022557163 @default.
• W2890427865 cites W2031379570 @default.
• W2890427865 cites W2037139573 @default.
• W2890427865 cites W2050434028 @default.
• W2890427865 cites W2054805907 @default.
• W2890427865 cites W2066195414 @default.
• W2890427865 cites W2073050603 @default.
• W2890427865 cites W2075343129 @default.
• W2890427865 cites W2095554214 @default.
• W2890427865 cites W2120294133 @default.
• W2890427865 cites W2121300496 @default.
• W2890427865 cites W2121949087 @default.
• W2890427865 cites W2130742313 @default.
• W2890427865 cites W2135836598 @default.
• W2890427865 cites W2136343307 @default.
• W2890427865 cites W2146236251 @default.
• W2890427865 cites W2148842621 @default.
• W2890427865 cites W2149146453 @default.
• W2890427865 cites W2155431361 @default.
• W2890427865 cites W2156172361 @default.
• W2890427865 cites W2156624473 @default.
• W2890427865 cites W2163642215 @default.
• W2890427865 cites W2165295475 @default.
• W2890427865 cites W2166650881 @default.
• W2890427865 cites W2171833185 @default.
• W2890427865 cites W2173463809 @default.
• W2890427865 cites W2215660606 @default.
• W2890427865 cites W2296623459 @default.
• W2890427865 cites W2328788814 @default.
• W2890427865 cites W2403305259 @default.
• W2890427865 cites W2404927328 @default.
• W2890427865 cites W2413298889 @default.
• W2890427865 cites W2531186635 @default.
• W2890427865 cites W2560911552 @default.
• W2890427865 cites W2561123102 @default.
• W2890427865 cites W2563045617 @default.
• W2890427865 cites W2570618306 @default.
• W2890427865 cites W2742175163 @default.
• W2890427865 cites W2752533957 @default.
• W2890427865 cites W2757042270 @default.
• W2890427865 cites W2917837889 @default.
• W2890427865 cites W3169336688 @default.
• W2890427865 doi "https://doi.org/10.1186/s13046-018-0882-4" @default.
• W2890427865 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6145328" @default.
• W2890427865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30227870" @default.
• W2890427865 hasPublicationYear "2018" @default.
• W2890427865 type Work @default.
• W2890427865 sameAs 2890427865 @default.
• W2890427865 citedByCount "39" @default.
• W2890427865 countsByYear W28904278652019 @default.
• W2890427865 countsByYear W28904278652020 @default.
• W2890427865 countsByYear W28904278652021 @default.
• W2890427865 countsByYear W28904278652022 @default.
• W2890427865 countsByYear W28904278652023 @default.
• W2890427865 crossrefType "journal-article" @default.
• W2890427865 hasAuthorship W2890427865A5006543483 @default.
• W2890427865 hasAuthorship W2890427865A5024958140 @default.
• W2890427865 hasAuthorship W2890427865A5044630419 @default.
• W2890427865 hasAuthorship W2890427865A5046597133 @default.
• W2890427865 hasAuthorship W2890427865A5049384131 @default.
• W2890427865 hasAuthorship W2890427865A5058338777 @default.
• W2890427865 hasAuthorship W2890427865A5061203415 @default.
• W2890427865 hasAuthorship W2890427865A5061370921 @default.
• W2890427865 hasAuthorship W2890427865A5069139703 @default.
• W2890427865 hasAuthorship W2890427865A5073501391 @default.
• W2890427865 hasAuthorship W2890427865A5074866697 @default.
• W2890427865 hasBestOaLocation W28904278651 @default.
• W2890427865 hasConcept C104317684 @default.
• W2890427865 hasConcept C142724271 @default.
• W2890427865 hasConcept C145059251 @default.

• next